BNY Mellon Concentrated International ETF (NYSEARCA:BKCI – Get Free Report) saw a large growth in short interest during the month of March. As of March 13th, there was short interest totaling 8,331 shares, a growth of 115.8% from the February 26th total of 3,861 shares. Based on an average daily volume of 32,404 shares, the short-interest ratio is currently 0.3 days. Currently, 0.2% of the shares of the company are short sold.
BNY Mellon Concentrated International ETF Price Performance
Shares of NYSEARCA:BKCI traded down $0.89 on Thursday, reaching $48.49. The company’s stock had a trading volume of 7,910 shares, compared to its average volume of 27,433. BNY Mellon Concentrated International ETF has a 52-week low of $42.85 and a 52-week high of $54.14. The stock has a market capitalization of $169.72 million, a P/E ratio of 23.08 and a beta of 0.87. The stock’s 50-day moving average is $51.94 and its two-hundred day moving average is $51.86.
BNY Mellon Concentrated International ETF Announces Dividend
The business also recently disclosed an annual dividend, which was paid on Friday, January 2nd. Shareholders of record on Monday, December 29th were paid a dividend of $0.7157 per share. The ex-dividend date of this dividend was Monday, December 29th. This represents a yield of 138.0%.
Institutional Inflows and Outflows
BNY Mellon Concentrated International ETF Company Profile
The BNY Mellon Concentrated International ETF (BKCI) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund relying heavily on fundamental research to select a narrow basket of stocks, of any market capitalization, from developed markets outside of the US. BKCI was launched on Dec 6, 2021 and is managed by BNY Mellon.
See Also
Receive News & Ratings for BNY Mellon Concentrated International ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BNY Mellon Concentrated International ETF and related companies with MarketBeat.com's FREE daily email newsletter.
